Virchow Drugs Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 2004.
2004 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Virchow Drugs Limited

Virchow Drugs Limited, a active public limited company, was established on 25 March 2004 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2004PLC042949. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹32.50 Cr and a paid-up capital of ₹12.24 Cr.

Formerly known as Virchow Drugs Private Limited. It upholds a compliant status. Employing 109 professional, Its leadership includes Narayana Reddy Mundla (Director), Abhinav Reddy Nandigala (Director), Sudha Mundla (Director). Past directors included Nicolas Spillmann, Christopher Newton, Venkata Reddy Alla. It holds ₹12.41 Cr open charges and no settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.9,S.V. Co-Op Indl Estate, Ida Jeedimetla, Hyderabad, Telangana, 500055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2004PLC042949

  • Registration Number

    042949

  • Incorporation Date

    25 March 2004

  • Authorized Capital

    ₹32.50 Cr

  • Paid-Up Capital

    ₹12.24 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 32.50 Cr
  • Paid Up Capital ₹ 12.24 Cr
  • Company Age 21 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 12.41 Cr
  • Revenue Growth **** 7.14%
  • Profit Growth **** 12.99%
  • Ebitda **** 12.20%
  • Net Worth 18.09%
  • Total Assets **** 14.25%
Company report

Virchow Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Virchow Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Virchow Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Narayana Reddy Mundla Director 25 Mar 2004 Current
Abhinav Reddy Nandigala Director 16 Dec 2024 Current
Sudha Mundla Director 31 Mar 2009 Current
Pamidi Ravindra Whole-Time Director 24 Dec 2020 Current
Prasanth Nandigala Director 12 Sep 2007 Current
Nauroji Reddy Alla Director 02 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Mar 2009 Past
Pramod Abcsdd Director 31 Mar 2009 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Additional Director 26 Sep 2025 Past
Pramod Abcsdd Chief Financial Officer - Past
Pramod Abcsdd Additional Director 29 Sep 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Virchow Drugs.

Virchow Drugs Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.14% increase. The company also saw a substantial improvement in profitability, with a 12.99% increase in profit. The company's net worth Soared by an impressive increase of 18.09%.

Virchow Drugs revenue growth over time
Virchow Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.14%
*******
*******
*******
*******
Revenue from Operations
*******
 6.60%
*******
*******
*******
*******
Total Assets
*******
 14.25%
*******
*******
*******
*******
Profit or Loss
*******
 12.99%
*******
*******
*******
*******
Net Worth
*******
 18.09%
*******
*******
*******
*******
EBITDA
*******
 12.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Virchow Drugs?

In 2021, Virchow Drugs had a promoter holding of 97.35% and a public holding of 2.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹124,100,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 12.41 Cr
Latest Charge Details
Date Lender Amount Status
22 Sep 2005 Canara Bank ₹12.41 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Virchow Drugs?

Virchow Drugs has a workforce of 109 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Virchow Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Virchow Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Virchow Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Virchow Drugs Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Nauroji Reddy Alla was appointed as a Director was appointed as a Director on 02 Jun 2025 & has been associated with this company since 8 months 18 days . was documented.

  • Director Appointment

    Progress on Ramakrishna Reddy Kona was appointed as a Director was appointed as a Director on 02 Jun 2025 & has been associated with this company since 8 months 18 days . was documented.

  • Balance Sheet

    Progress on Virchow Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Abhinav Reddy Nandigala was appointed as a Director was appointed as a Director on 16 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Pamidi Ravindra was appointed as a CFO was appointed as a CFO on 01 Apr 2021 & has been associated with this company since 4 years 10 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Virchow Drugs Limited?

The CIN of Virchow Drugs Limited is U24239TG2004PLC042949.

Where is Virchow Drugs Limited headquartered?

Virchow Drugs Limited is headquartered at Plot No.9,S.V. Co-Op Indl Estate, Ida Jeedimetla, Hyderabad, Telangana, 500055.

When was Virchow Drugs Limited incorporated?

Virchow Drugs Limited was incorporated on 25 March 2004.

Who are the current directors of Virchow Drugs Limited?

The current directors of Virchow Drugs Limited are

What is the primary industry of Virchow Drugs Limited?

The primary industry of Virchow Drugs Limited is Manufacturing.

Is Virchow Drugs Limited a listed company?

Virchow Drugs Limited is unlisted.

What is the capital structure of Virchow Drugs Limited?

The authorized capital of Virchow Drugs Limited is ₹32.50 Cr, and the paid-up capital is ₹12.24 Cr.

What is the compliance status of Virchow Drugs Limited?

The compliance status of Virchow Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available